Skip to main content
Erschienen in: American Journal of Clinical Dermatology 4/2017

01.08.2017 | Review Article

Cutaneous Manifestations of Diabetes Mellitus: A Review

verfasst von: Ana Luiza Lima, Tanja Illing, Sibylle Schliemann, Peter Elsner

Erschienen in: American Journal of Clinical Dermatology | Ausgabe 4/2017

Einloggen, um Zugang zu erhalten

Abstract

Diabetes mellitus is a widespread endocrine disease with severe impact on health systems worldwide. Increased serum glucose causes damage to a wide range of cell types, including endothelial cells, neurons, and renal cells, but also keratinocytes and fibroblasts. Skin disorders can be found in about one third of all people with diabetes and frequently occur before the diagnosis, thus playing an important role in the initial recognition of underlying disease. Noninfectious as well as infectious diseases have been described as dermatologic manifestations of diabetes mellitus. Moreover, diabetic neuropathy and angiopathy may also affect the skin. Pruritus, necrobiosis lipoidica, scleredema adultorum of Buschke, and granuloma annulare are examples of frequent noninfectious skin diseases. Bacterial and fungal skin infections are more frequent in people with diabetes. Diabetic neuropathy and angiopathy are responsible for diabetic foot syndrome and diabetic dermopathy. Furthermore, antidiabetic therapies may provoke dermatologic adverse events. Treatment with insulin may evoke local reactions like lipohypertrophy, lipoatrophy and both instant and delayed type allergy. Erythema multiforme, leukocytoclastic vasculitis, drug eruptions, and photosensitivity have been described as adverse reactions to oral antidiabetics. The identification of lesions may be crucial for the first diagnosis and for proper therapy of diabetes.
Literatur
2.
Zurück zum Zitat Perez MI, Kohn SR. Cutaneous manifestations of diabetes mellitus. J Am Acad Dermatol. 1994;30(4):519–31; quiz 32-4. Perez MI, Kohn SR. Cutaneous manifestations of diabetes mellitus. J Am Acad Dermatol. 1994;30(4):519–31; quiz 32-4.
5.
Zurück zum Zitat American Diabetes A. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2004;27(Suppl 1):S5–10. American Diabetes A. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2004;27(Suppl 1):S5–10.
11.
Zurück zum Zitat Jallut D, Golay A, Munger R, Frascarolo P, Schutz Y, Jequier E, et al. Impaired glucose tolerance and diabetes in obesity: a 6-year follow-up study of glucose metabolism. Metabolism. 1990;39(10):1068–75.PubMedCrossRef Jallut D, Golay A, Munger R, Frascarolo P, Schutz Y, Jequier E, et al. Impaired glucose tolerance and diabetes in obesity: a 6-year follow-up study of glucose metabolism. Metabolism. 1990;39(10):1068–75.PubMedCrossRef
12.
Zurück zum Zitat Bastard JP, Maachi M, Lagathu C, Kim MJ, Caron M, Vidal H, et al. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw. 2006;17(1):4–12.PubMed Bastard JP, Maachi M, Lagathu C, Kim MJ, Caron M, Vidal H, et al. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw. 2006;17(1):4–12.PubMed
13.
Zurück zum Zitat Metzger BE, Coustan DR. Summary and recommendations of the Fourth International Workshop-Conference on Gestational Diabetes Mellitus. The Organizing Committee. Diabetes Care. 1998;21(Suppl 2):B161–7.PubMed Metzger BE, Coustan DR. Summary and recommendations of the Fourth International Workshop-Conference on Gestational Diabetes Mellitus. The Organizing Committee. Diabetes Care. 1998;21(Suppl 2):B161–7.PubMed
14.
Zurück zum Zitat Baz B, Riveline JP, Gautier JF. ENDOCRINOLOGY OF PREGNANCY: gestational diabetes mellitus: definition, aetiological and clinical aspects. Eur J Endocrinol. 2016;174(2):R43–51. doi:10.1530/EJE-15-0378.PubMedCrossRef Baz B, Riveline JP, Gautier JF. ENDOCRINOLOGY OF PREGNANCY: gestational diabetes mellitus: definition, aetiological and clinical aspects. Eur J Endocrinol. 2016;174(2):R43–51. doi:10.​1530/​EJE-15-0378.PubMedCrossRef
16.
Zurück zum Zitat Catalano PM, Tyzbir ED, Wolfe RR, Calles J, Roman NM, Amini SB, et al. Carbohydrate metabolism during pregnancy in control subjects and women with gestational diabetes. Am J Physiol. 1993;264(1 Pt 1):E60–7.PubMed Catalano PM, Tyzbir ED, Wolfe RR, Calles J, Roman NM, Amini SB, et al. Carbohydrate metabolism during pregnancy in control subjects and women with gestational diabetes. Am J Physiol. 1993;264(1 Pt 1):E60–7.PubMed
20.
Zurück zum Zitat WHO. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: report of a WHO/IDF consultation. Geneva: WHO; 2006. WHO. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: report of a WHO/IDF consultation. Geneva: WHO; 2006.
21.
Zurück zum Zitat ADA. Standards of medical care in diabetes—2010. Diabetes Care. 2010;33(Suppl. 1):S11–61. ADA. Standards of medical care in diabetes—2010. Diabetes Care. 2010;33(Suppl. 1):S11–61.
22.
Zurück zum Zitat Palimeri S, Palioura E, Diamanti-Kandarakis E. Current perspectives on the health risks associated with the consumption of advanced glycation end products: recommendations for dietary management. Diabetes Metab Syndr Obes. 2015;8:415–26. doi:10.2147/DMSO.S63089.PubMedPubMedCentral Palimeri S, Palioura E, Diamanti-Kandarakis E. Current perspectives on the health risks associated with the consumption of advanced glycation end products: recommendations for dietary management. Diabetes Metab Syndr Obes. 2015;8:415–26. doi:10.​2147/​DMSO.​S63089.PubMedPubMedCentral
25.
Zurück zum Zitat Stern D, Yan SD, Yan SF, Schmidt AM. Receptor for advanced glycation endproducts: a multiligand receptor magnifying cell stress in diverse pathologic settings. Adv Drug Deliv Rev. 2002;54(12):1615–25.PubMedCrossRef Stern D, Yan SD, Yan SF, Schmidt AM. Receptor for advanced glycation endproducts: a multiligand receptor magnifying cell stress in diverse pathologic settings. Adv Drug Deliv Rev. 2002;54(12):1615–25.PubMedCrossRef
26.
28.
Zurück zum Zitat Ko MJ, Chiu HC, Jee SH, Hu FC, Tseng CH. Postprandial blood glucose is associated with generalized pruritus in patients with type 2 diabetes. Eur J Dermatol. 2013;23(5):688–93. doi:10.1684/ejd.2013.2100.PubMed Ko MJ, Chiu HC, Jee SH, Hu FC, Tseng CH. Postprandial blood glucose is associated with generalized pruritus in patients with type 2 diabetes. Eur J Dermatol. 2013;23(5):688–93. doi:10.​1684/​ejd.​2013.​2100.PubMed
34.
Zurück zum Zitat Zylicz Z, Krajnik M, Sorge AA, Costantini M. Paroxetine in the treatment of severe non-dermatological pruritus: a randomized, controlled trial. J Pain Symptom Manage. 2003;26(6):1105–12.PubMedCrossRef Zylicz Z, Krajnik M, Sorge AA, Costantini M. Paroxetine in the treatment of severe non-dermatological pruritus: a randomized, controlled trial. J Pain Symptom Manage. 2003;26(6):1105–12.PubMedCrossRef
36.
Zurück zum Zitat Cohen O, Yaniv R, Karasik A, Trau H. Necrobiosis lipoidica and diabetic control revisited. Med Hypotheses. 1996;46(4):348–50.PubMedCrossRef Cohen O, Yaniv R, Karasik A, Trau H. Necrobiosis lipoidica and diabetic control revisited. Med Hypotheses. 1996;46(4):348–50.PubMedCrossRef
37.
39.
Zurück zum Zitat Jiquan S, Khalaf AT, Jinquan T, Xiaoming L. Necrobiosis lipoidica: a case with histopathological findings revealed asteroid bodies and was successfully treated with dipyridamole plus intralesional triamcinolone. J Dermatol Treat. 2008;19(1):54–7. doi:10.1080/09546630701691228.CrossRef Jiquan S, Khalaf AT, Jinquan T, Xiaoming L. Necrobiosis lipoidica: a case with histopathological findings revealed asteroid bodies and was successfully treated with dipyridamole plus intralesional triamcinolone. J Dermatol Treat. 2008;19(1):54–7. doi:10.​1080/​0954663070169122​8.CrossRef
41.
Zurück zum Zitat Suarez-Amor O, Perez-Bustillo A, Ruiz-Gonzalez I, Rodriguez-Prieto MA. Necrobiosis lipoidica therapy with biologicals: an ulcerated case responding to etanercept and a review of the literature. Dermatology. 2010;221(2):117–21. doi:10.1159/000314694.PubMed Suarez-Amor O, Perez-Bustillo A, Ruiz-Gonzalez I, Rodriguez-Prieto MA. Necrobiosis lipoidica therapy with biologicals: an ulcerated case responding to etanercept and a review of the literature. Dermatology. 2010;221(2):117–21. doi:10.​1159/​000314694.PubMed
44.
Zurück zum Zitat Erfurt-Berge C, Seitz AT, Rehse C, Wollina U, Schwede K, Renner R. Update on clinical and laboratory features in necrobiosis lipoidica: a retrospective multicentre study of 52 patients. Eur J Dermatol. 2012;22(6):770–5. doi:10.1684/ejd.2012.1839.PubMed Erfurt-Berge C, Seitz AT, Rehse C, Wollina U, Schwede K, Renner R. Update on clinical and laboratory features in necrobiosis lipoidica: a retrospective multicentre study of 52 patients. Eur J Dermatol. 2012;22(6):770–5. doi:10.​1684/​ejd.​2012.​1839.PubMed
46.
Zurück zum Zitat Angeli-Besson C, Koeppel MC, Jacquet P, Andrac L, Sayag J. Electron-beam therapy in scleredema adultorum with associated monoclonal hypergammaglobulinaemia. Br J Dermatol. 1994;130(3):394–7.PubMedCrossRef Angeli-Besson C, Koeppel MC, Jacquet P, Andrac L, Sayag J. Electron-beam therapy in scleredema adultorum with associated monoclonal hypergammaglobulinaemia. Br J Dermatol. 1994;130(3):394–7.PubMedCrossRef
47.
Zurück zum Zitat Dinato SL, Costa GL, Dinato MC, Sementilli A, Romiti N. Scleredema of Buschke associated with diabetes mellitus type 2: case report and review of the literature. Arq Bras Endocrinol Metabol. 2010;54(9):852–5.PubMedCrossRef Dinato SL, Costa GL, Dinato MC, Sementilli A, Romiti N. Scleredema of Buschke associated with diabetes mellitus type 2: case report and review of the literature. Arq Bras Endocrinol Metabol. 2010;54(9):852–5.PubMedCrossRef
50.
Zurück zum Zitat Aye M, Masson EA. Dermatological care of the diabetic foot. Am J Clin Dermatol. 2002;3(7):463–74.PubMedCrossRef Aye M, Masson EA. Dermatological care of the diabetic foot. Am J Clin Dermatol. 2002;3(7):463–74.PubMedCrossRef
51.
Zurück zum Zitat Basarab T, Munn SE, McGrath J, Russell Jones R. Bullosis diabeticorum. A case report and literature review. Clin Exp Dermatol. 1995;20(3):218–20.PubMedCrossRef Basarab T, Munn SE, McGrath J, Russell Jones R. Bullosis diabeticorum. A case report and literature review. Clin Exp Dermatol. 1995;20(3):218–20.PubMedCrossRef
52.
Zurück zum Zitat Nebesio CL, Lewis C, Chuang TY. Lack of an association between granuloma annulare and type 2 diabetes mellitus. Br J Dermatol. 2002;146(1):122–4.PubMedCrossRef Nebesio CL, Lewis C, Chuang TY. Lack of an association between granuloma annulare and type 2 diabetes mellitus. Br J Dermatol. 2002;146(1):122–4.PubMedCrossRef
53.
Zurück zum Zitat Goucha S, Khaled A, Kharfi M, Fazaa B, Zermani R, Ben Jilani S, et al. Granuloma annulare. G Ital Dermatol Venereol. 2008;143(6):359–63.PubMed Goucha S, Khaled A, Kharfi M, Fazaa B, Zermani R, Ben Jilani S, et al. Granuloma annulare. G Ital Dermatol Venereol. 2008;143(6):359–63.PubMed
55.
Zurück zum Zitat Li A, Hogan DJ, Sanusi ID, Smoller BR. Granuloma annulare and malignant neoplasms. Am J Dermatopathol. 2003;25(2):113–6.PubMedCrossRef Li A, Hogan DJ, Sanusi ID, Smoller BR. Granuloma annulare and malignant neoplasms. Am J Dermatopathol. 2003;25(2):113–6.PubMedCrossRef
57.
Zurück zum Zitat Milicic V, Ravic-Nikolic A, Jovovic-Dagovic B, Ristic G, Mitrovic S. Generalized granuloma annulare presenting as arcuate dermal erythema. Acta Dermatovenerol Alp Pannonica Adriat. 2010;19(1):25–7.PubMed Milicic V, Ravic-Nikolic A, Jovovic-Dagovic B, Ristic G, Mitrovic S. Generalized granuloma annulare presenting as arcuate dermal erythema. Acta Dermatovenerol Alp Pannonica Adriat. 2010;19(1):25–7.PubMed
58.
Zurück zum Zitat Rubel DM, Wood G, Rosen R, Jopp-McKay A. Generalised granuloma annulare successfully treated with pentoxifylline. Australas J Dermatol. 1993;34(3):103–8.PubMedCrossRef Rubel DM, Wood G, Rosen R, Jopp-McKay A. Generalised granuloma annulare successfully treated with pentoxifylline. Australas J Dermatol. 1993;34(3):103–8.PubMedCrossRef
59.
Zurück zum Zitat Hermanns-Le T, Scheen A, Pierard GE. Acanthosis nigricans associated with insulin resistance: pathophysiology and management. Am J Clin Dermatol. 2004;5(3):199–203.PubMedCrossRef Hermanns-Le T, Scheen A, Pierard GE. Acanthosis nigricans associated with insulin resistance: pathophysiology and management. Am J Clin Dermatol. 2004;5(3):199–203.PubMedCrossRef
60.
Zurück zum Zitat Stoddart ML, Blevins KS, Lee ET, Wang W, Blackett PR, Cherokee Diabetes S. Association of acanthosis nigricans with hyperinsulinemia compared with other selected risk factors for type 2 diabetes in Cherokee Indians: the Cherokee Diabetes Study. Diabetes Care. 2002;25(6):1009–14.PubMedCrossRef Stoddart ML, Blevins KS, Lee ET, Wang W, Blackett PR, Cherokee Diabetes S. Association of acanthosis nigricans with hyperinsulinemia compared with other selected risk factors for type 2 diabetes in Cherokee Indians: the Cherokee Diabetes Study. Diabetes Care. 2002;25(6):1009–14.PubMedCrossRef
62.
Zurück zum Zitat Apridonidze T, Essah PA, Iuorno MJ, Nestler JE. Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2005;90(4):1929–35. doi:10.1210/jc.2004-1045.PubMedCrossRef Apridonidze T, Essah PA, Iuorno MJ, Nestler JE. Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2005;90(4):1929–35. doi:10.​1210/​jc.​2004-1045.PubMedCrossRef
65.
Zurück zum Zitat Stals H, Vercammen C, Peeters C, Morren MA. Acanthosis nigricans caused by nicotinic acid: case report and review of the literature. Dermatology. 1994;189(2):203–6.PubMedCrossRef Stals H, Vercammen C, Peeters C, Morren MA. Acanthosis nigricans caused by nicotinic acid: case report and review of the literature. Dermatology. 1994;189(2):203–6.PubMedCrossRef
67.
Zurück zum Zitat Amer AA, Gao XH. Quality of life in patients with vitiligo: an analysis of the dermatology life quality index outcome over the past two decades. Int J Dermatol. 2016;55(6):608–14. doi:10.1111/ijd.13198.PubMedCrossRef Amer AA, Gao XH. Quality of life in patients with vitiligo: an analysis of the dermatology life quality index outcome over the past two decades. Int J Dermatol. 2016;55(6):608–14. doi:10.​1111/​ijd.​13198.PubMedCrossRef
68.
Zurück zum Zitat Martis J, Bhat R, Nandakishore B, Shetty JN. A clinical study of vitiligo. Indian J Dermatol Venereol Leprol. 2002;68(2):92–3.PubMed Martis J, Bhat R, Nandakishore B, Shetty JN. A clinical study of vitiligo. Indian J Dermatol Venereol Leprol. 2002;68(2):92–3.PubMed
69.
Zurück zum Zitat Whitton M, Pinart M, Batchelor JM, Leonardi-Bee J, Gonzalez U, Jiyad Z, et al. Evidence-based management of vitiligo: summary of a Cochrane systematic review. Br J Dermatol. 2016;174(5):962–9. doi:10.1111/bjd.14356.PubMedCrossRef Whitton M, Pinart M, Batchelor JM, Leonardi-Bee J, Gonzalez U, Jiyad Z, et al. Evidence-based management of vitiligo: summary of a Cochrane systematic review. Br J Dermatol. 2016;174(5):962–9. doi:10.​1111/​bjd.​14356.PubMedCrossRef
71.
Zurück zum Zitat Nikoleishvili LR, Kurashvili RB, Virsaladze DK, Khachapuridze NG, Kurashvili LR. Characteristic changes of skin and its accessories in type 2 diabetes mellitus. Georgian Med News. 2006;131:43–6. Nikoleishvili LR, Kurashvili RB, Virsaladze DK, Khachapuridze NG, Kurashvili LR. Characteristic changes of skin and its accessories in type 2 diabetes mellitus. Georgian Med News. 2006;131:43–6.
72.
Zurück zum Zitat Suzuki K, Ito Y, Nakamura S, Ochiai J, Aoki K. Relationship between serum carotenoids and hyperglycemia: a population-based cross-sectional study. J Epidemiol. 2002;12(5):357–66.PubMedCrossRef Suzuki K, Ito Y, Nakamura S, Ochiai J, Aoki K. Relationship between serum carotenoids and hyperglycemia: a population-based cross-sectional study. J Epidemiol. 2002;12(5):357–66.PubMedCrossRef
75.
Zurück zum Zitat Manousaridis I, Manousaridis K, Peitsch WK, Schneider SW. Individualizing treatment and choice of medication in lichen planus: a step by step approach. J Dtsch Dermatol Ges. 2013;11(10):981–91. doi:10.1111/ddg.12141.PubMed Manousaridis I, Manousaridis K, Peitsch WK, Schneider SW. Individualizing treatment and choice of medication in lichen planus: a step by step approach. J Dtsch Dermatol Ges. 2013;11(10):981–91. doi:10.​1111/​ddg.​12141.PubMed
78.
79.
Zurück zum Zitat Yancovitz M, Johnson H, Wang N, Pomeranz MK. Perforating collagenosis. Dermatol Online J. 2008;14(10):14.PubMed Yancovitz M, Johnson H, Wang N, Pomeranz MK. Perforating collagenosis. Dermatol Online J. 2008;14(10):14.PubMed
80.
Zurück zum Zitat Nebel R, Fiedler E, Danz B, Marsch WC, Kreft B. Acquired reactive perforating collagenosis associated with diabetes mellitus and renal insufficiency requiring dialysis. Dtsch Med Wochenschr. 2007;132(49):2624–6. doi:10.1055/s-2007-993108.PubMedCrossRef Nebel R, Fiedler E, Danz B, Marsch WC, Kreft B. Acquired reactive perforating collagenosis associated with diabetes mellitus and renal insufficiency requiring dialysis. Dtsch Med Wochenschr. 2007;132(49):2624–6. doi:10.​1055/​s-2007-993108.PubMedCrossRef
86.
Zurück zum Zitat American Diabetes A. Peripheral arterial disease in people with diabetes. Diabetes Care. 2003;26(12):3333–41.CrossRef American Diabetes A. Peripheral arterial disease in people with diabetes. Diabetes Care. 2003;26(12):3333–41.CrossRef
90.
Zurück zum Zitat Perkins BA, Olaleye D, Bril V. Carpal tunnel syndrome in patients with diabetic polyneuropathy. Diabetes Care. 2002;25(3):565–9.PubMedCrossRef Perkins BA, Olaleye D, Bril V. Carpal tunnel syndrome in patients with diabetic polyneuropathy. Diabetes Care. 2002;25(3):565–9.PubMedCrossRef
95.
Zurück zum Zitat Yosipovitch G, Tur E, Cohen O, Rusecki Y. Skin surface pH in intertriginous areas in NIDDM patients. Possible correlation to candidal intertrigo. Diabetes Care. 1993;16(4):560–3.PubMedCrossRef Yosipovitch G, Tur E, Cohen O, Rusecki Y. Skin surface pH in intertriginous areas in NIDDM patients. Possible correlation to candidal intertrigo. Diabetes Care. 1993;16(4):560–3.PubMedCrossRef
97.
Zurück zum Zitat Sunderkotter C, Becker K. Frequent bacterial skin and soft tissue infections: diagnostic signs and treatment. J Dtsch Dermatol Ges. 2015;13(6):501–24; quiz 25-6. doi:10.1111/ddg.12721. Sunderkotter C, Becker K. Frequent bacterial skin and soft tissue infections: diagnostic signs and treatment. J Dtsch Dermatol Ges. 2015;13(6):501–24; quiz 25-6. doi:10.​1111/​ddg.​12721.
103.
Zurück zum Zitat Wong CH, Chang HC, Pasupathy S, Khin LW, Tan JL, Low CO. Necrotizing fasciitis: clinical presentation, microbiology, and determinants of mortality. J Bone Jt Surg Am. 2003;85-A(8):1454–60.CrossRef Wong CH, Chang HC, Pasupathy S, Khin LW, Tan JL, Low CO. Necrotizing fasciitis: clinical presentation, microbiology, and determinants of mortality. J Bone Jt Surg Am. 2003;85-A(8):1454–60.CrossRef
105.
Zurück zum Zitat Rubin Grandis J, Branstetter BFT, Yu VL. The changing face of malignant (necrotising) external otitis: clinical, radiological, and anatomic correlations. Lancet Infect Dis. 2004;4(1):34–9.PubMedCrossRef Rubin Grandis J, Branstetter BFT, Yu VL. The changing face of malignant (necrotising) external otitis: clinical, radiological, and anatomic correlations. Lancet Infect Dis. 2004;4(1):34–9.PubMedCrossRef
106.
Zurück zum Zitat Gupta AK, Konnikov N, MacDonald P, Rich P, Rodger NW, Edmonds MW, et al. Prevalence and epidemiology of toenail onychomycosis in diabetic subjects: a multicentre survey. Br J Dermatol. 1998;139(4):665–71.PubMedCrossRef Gupta AK, Konnikov N, MacDonald P, Rich P, Rodger NW, Edmonds MW, et al. Prevalence and epidemiology of toenail onychomycosis in diabetic subjects: a multicentre survey. Br J Dermatol. 1998;139(4):665–71.PubMedCrossRef
107.
Zurück zum Zitat Lugo-Somolinos A, Sanchez JL. Prevalence of dermatophytosis in patients with diabetes. J Am Acad Dermatol. 1992;26(3 Pt 2):408–10.PubMedCrossRef Lugo-Somolinos A, Sanchez JL. Prevalence of dermatophytosis in patients with diabetes. J Am Acad Dermatol. 1992;26(3 Pt 2):408–10.PubMedCrossRef
108.
Zurück zum Zitat de Leon EM, Jacober SJ, Sobel JD, Foxman B. Prevalence and risk factors for vaginal Candida colonization in women with type 1 and type 2 diabetes. BMC Infect Dis. 2002;2:1.PubMedPubMedCentralCrossRef de Leon EM, Jacober SJ, Sobel JD, Foxman B. Prevalence and risk factors for vaginal Candida colonization in women with type 1 and type 2 diabetes. BMC Infect Dis. 2002;2:1.PubMedPubMedCentralCrossRef
110.
Zurück zum Zitat Rashid M, Bari A, Majeed S, Tariq KM, Haq I, Niwaz A. Mucormycosis: a devastating fungal infection in diabetics. J Coll Physicians Surg Pak. 2005;15(1):43–5. doi:01.2005/JCPSP.4345. Rashid M, Bari A, Majeed S, Tariq KM, Haq I, Niwaz A. Mucormycosis: a devastating fungal infection in diabetics. J Coll Physicians Surg Pak. 2005;15(1):43–5. doi:01.2005/JCPSP.4345.
112.
Zurück zum Zitat Prabhu RM, Patel R. Mucormycosis and entomophthoramycosis: a review of the clinical manifestations, diagnosis and treatment. Clin Microbiol Infect. 2004;10(Suppl 1):31–47.PubMedCrossRef Prabhu RM, Patel R. Mucormycosis and entomophthoramycosis: a review of the clinical manifestations, diagnosis and treatment. Clin Microbiol Infect. 2004;10(Suppl 1):31–47.PubMedCrossRef
113.
Zurück zum Zitat Richardson T, Kerr D. Skin-related complications of insulin therapy: epidemiology and emerging management strategies. Am J Clin Dermatol. 2003;4(10):661–7.PubMedCrossRef Richardson T, Kerr D. Skin-related complications of insulin therapy: epidemiology and emerging management strategies. Am J Clin Dermatol. 2003;4(10):661–7.PubMedCrossRef
114.
Zurück zum Zitat Young RJ, Hannan WJ, Frier BM, Steel JM, Duncan LJ. Diabetic lipohypertrophy delays insulin absorption. Diabetes Care. 1984;7(5):479–80.PubMedCrossRef Young RJ, Hannan WJ, Frier BM, Steel JM, Duncan LJ. Diabetic lipohypertrophy delays insulin absorption. Diabetes Care. 1984;7(5):479–80.PubMedCrossRef
115.
116.
Zurück zum Zitat Beltrand J, Guilmin-Crepon S, Castanet M, Peuchmaur M, Czernichow P, Levy-Marchal C. Insulin allergy and extensive lipoatrophy in child with type 1 diabetes. Horm Res. 2006;65(5):253–60. doi:10.1159/000092515.PubMed Beltrand J, Guilmin-Crepon S, Castanet M, Peuchmaur M, Czernichow P, Levy-Marchal C. Insulin allergy and extensive lipoatrophy in child with type 1 diabetes. Horm Res. 2006;65(5):253–60. doi:10.​1159/​000092515.PubMed
117.
Zurück zum Zitat Havel PJ. Update on adipocyte hormones: regulation of energy balance and carbohydrate/lipid metabolism. Diabetes. 2004;53(Suppl 1):S143–51.PubMedCrossRef Havel PJ. Update on adipocyte hormones: regulation of energy balance and carbohydrate/lipid metabolism. Diabetes. 2004;53(Suppl 1):S143–51.PubMedCrossRef
118.
Zurück zum Zitat Radermecker RP, Pierard GE, Scheen AJ. Lipodystrophy reactions to insulin: effects of continuous insulin infusion and new insulin analogs. Am J Clin Dermatol. 2007;8(1):21–8.PubMedCrossRef Radermecker RP, Pierard GE, Scheen AJ. Lipodystrophy reactions to insulin: effects of continuous insulin infusion and new insulin analogs. Am J Clin Dermatol. 2007;8(1):21–8.PubMedCrossRef
119.
Zurück zum Zitat Scheer BG, Sitz KV. Suspected insulin anaphylaxis and literature review. J Ark Med Soc. 2001;97(9):311–3.PubMed Scheer BG, Sitz KV. Suspected insulin anaphylaxis and literature review. J Ark Med Soc. 2001;97(9):311–3.PubMed
121.
Zurück zum Zitat Blanco C, Castillo R, Quiralte J, Delgado J, Garcia I, de Pablos P, et al. Anaphylaxis to subcutaneous neutral protamine Hagedorn insulin with simultaneous sensitization to protamine and insulin. Allergy. 1996;51(6):421–4.PubMed Blanco C, Castillo R, Quiralte J, Delgado J, Garcia I, de Pablos P, et al. Anaphylaxis to subcutaneous neutral protamine Hagedorn insulin with simultaneous sensitization to protamine and insulin. Allergy. 1996;51(6):421–4.PubMed
122.
124.
Zurück zum Zitat Fujii S, Nakashima T, Kaneko T. Glibenclamide-induced photosensitivity in a diabetic patient with erythropoietic protoporphyria. Am J Hematol. 1995;50(3):223.PubMedCrossRef Fujii S, Nakashima T, Kaneko T. Glibenclamide-induced photosensitivity in a diabetic patient with erythropoietic protoporphyria. Am J Hematol. 1995;50(3):223.PubMedCrossRef
125.
Zurück zum Zitat Noakes R. Lichenoid drug eruption as a result of the recently released sulfonylurea glimepiride. Australas J Dermatol. 2003;44(4):302–3.PubMedCrossRef Noakes R. Lichenoid drug eruption as a result of the recently released sulfonylurea glimepiride. Australas J Dermatol. 2003;44(4):302–3.PubMedCrossRef
126.
Zurück zum Zitat Lao B, Czyzyk A, Szutowski M, Szczepanik Z. Alcohol tolerance in patients with non-insulin-dependent (type 2) diabetes treated with sulphonylurea derivatives. Arzneimittelforschung. 1994;44(6):727–34.PubMed Lao B, Czyzyk A, Szutowski M, Szczepanik Z. Alcohol tolerance in patients with non-insulin-dependent (type 2) diabetes treated with sulphonylurea derivatives. Arzneimittelforschung. 1994;44(6):727–34.PubMed
127.
Zurück zum Zitat Franz CB, Massullo RE, Welton WA. Lichenoid drug eruption from chlorpropamide and tolazamide. J Am Acad Dermatol. 1990;22(1):128–9.PubMedCrossRef Franz CB, Massullo RE, Welton WA. Lichenoid drug eruption from chlorpropamide and tolazamide. J Am Acad Dermatol. 1990;22(1):128–9.PubMedCrossRef
128.
Zurück zum Zitat Goh CL. Psoriasiform drug eruption due to glibenclamide. Australas J Dermatol. 1987;28(1):30–2.PubMedCrossRef Goh CL. Psoriasiform drug eruption due to glibenclamide. Australas J Dermatol. 1987;28(1):30–2.PubMedCrossRef
129.
Zurück zum Zitat Paterson AJ, Lamey PJ, Lewis MA, Nolan A, Rademaker M. Pemphigus vulgaris precipitated by glibenclamide therapy. J Oral Pathol Med. 1993;22(2):92–5.PubMedCrossRef Paterson AJ, Lamey PJ, Lewis MA, Nolan A, Rademaker M. Pemphigus vulgaris precipitated by glibenclamide therapy. J Oral Pathol Med. 1993;22(2):92–5.PubMedCrossRef
130.
Zurück zum Zitat Goldberg I, Sasson A, Gat A, Srebrnik A, Brenner S. Pemphigus vulgaris triggered by glibenclamide and cilazapril. Acta Dermatovenerol Croat. 2005;13(3):153–5.PubMed Goldberg I, Sasson A, Gat A, Srebrnik A, Brenner S. Pemphigus vulgaris triggered by glibenclamide and cilazapril. Acta Dermatovenerol Croat. 2005;13(3):153–5.PubMed
131.
Zurück zum Zitat Koca R, Altinyazar HC, Yenidunya S, Tekin NS. Psoriasiform drug eruption associated with metformin hydrochloride: a case report. Dermatol Online J. 2003;9(3):11.PubMed Koca R, Altinyazar HC, Yenidunya S, Tekin NS. Psoriasiform drug eruption associated with metformin hydrochloride: a case report. Dermatol Online J. 2003;9(3):11.PubMed
Metadaten
Titel
Cutaneous Manifestations of Diabetes Mellitus: A Review
verfasst von
Ana Luiza Lima
Tanja Illing
Sibylle Schliemann
Peter Elsner
Publikationsdatum
01.08.2017
Verlag
Springer International Publishing
Erschienen in
American Journal of Clinical Dermatology / Ausgabe 4/2017
Print ISSN: 1175-0561
Elektronische ISSN: 1179-1888
DOI
https://doi.org/10.1007/s40257-017-0275-z

Weitere Artikel der Ausgabe 4/2017

American Journal of Clinical Dermatology 4/2017 Zur Ausgabe

Leitlinien kompakt für die Dermatologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Medizinstudium Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Endlich: Zi zeigt, mit welchen PVS Praxen zufrieden sind

IT für Ärzte Nachrichten

Darauf haben viele Praxen gewartet: Das Zi hat eine Liste von Praxisverwaltungssystemen veröffentlicht, die von Nutzern positiv bewertet werden. Eine gute Grundlage für wechselwillige Ärztinnen und Psychotherapeuten.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders scheint das auf weibliche Kranke zuzutreffen, wie eine Studie zeigt.

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

26.04.2024 Hirsutismus Nachrichten

Laser- und Lichtbehandlungen können bei Frauen mit polyzystischem Ovarialsyndrom (PCOS) den übermäßigen Haarwuchs verringern und das Wohlbefinden verbessern – bei alleiniger Anwendung oder in Kombination mit Medikamenten.

Update Dermatologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.